GSK/Novartis to divest OTC brands in Europe

29 January 2015 - Deborah Wilkes

Archived

GlaxoSmithKline and Novartis have agreed to divest several OTC brands in Europe to gain approval from the European Commission for the formation of the global consumer healthcare joint venture between the two companies. A spokesperson for GlaxoSmithKline told OTCToolbox the companies were in the process of identifying buyers for the OTC brands.

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: